🇫🇷
France · FR · FR:65571438
GLICLAZIDE MYLAN PHARMA 60 mg, comprimé à libération modifiée
ReimbursedATC A10BB09
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerMYLAN SAS
CountryFR (France)
ATC codeA10BB09
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 2
- cip133400926914226plaquette(s) polyamide aluminium PVC-Aluminium de 30 comprimé(s)EUR 2.92
- cip133400926914684plaquette(s) polyamide aluminium PVC-Aluminium de 90 comprimé(s)EUR 8.22
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "65571438",
"date_amm": "2013-08-01",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé à libération modifiée",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code A10BB09.
- CAAG-GLICLAZIDE MRANGITA PHARMA INC.
- CAAG-GLICLAZIDE MRANGITA PHARMA INC.
- CAAPO-GLICLAZIDEAPOTEX INC
- CAAPO-GLICLAZIDE MRAPOTEX INC
- CAAPO-GLICLAZIDE MRAPOTEX INC
- GBBilxona 30mg modified-release tabletsAccord-UK Ltd
- GBBilxona 60mg modified-release tabletsActavis UK Ltd
- GBBilxona 60mg modified-release tabletsAccord-UK Ltd
Access this data programmatically
Query GLICLAZIDE MYLAN PHARMA 60 mg, comprimé à libération modifiée and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.